Drugs for Short Bowel Syndrome Market - Global Outlook and Forecast 2021-2027

Code: RW00014535598
Market Monitor Global
Oct-2021
Life Sciences
90 Pages

This report contains market size and forecasts of Drugs for Short Bowel Syndrome in Global, including the following market information:
Global Drugs for Short Bowel Syndrome Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Drugs for Short Bowel Syndrome market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Short Bowel Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Short Bowel Syndrome Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, By Type, 2020 (%)
GLP-2
Growth Hormone
Glutamine
Other

China Drugs for Short Bowel Syndrome Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Drugs for Short Bowel Syndrome Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Drugs for Short Bowel Syndrome Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Drugs for Short Bowel Syndrome Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Drugs for Short Bowel Syndrome Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Ardelyx
Emmaus Life Sciences
GLyPharma Therapeutic
Merck
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio & Company
Takeda
Zealand Pharma

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Drugs for Short Bowel Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Short Bowel Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Short Bowel Syndrome Overall Market Size
2.1 Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2027
2.2 Global Drugs for Short Bowel Syndrome Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Short Bowel Syndrome Players in Global Market
3.2 Top Global Drugs for Short Bowel Syndrome Companies Ranked by Revenue
3.3 Global Drugs for Short Bowel Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Short Bowel Syndrome Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drugs for Short Bowel Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Short Bowel Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Short Bowel Syndrome Market Size Markets, 2021 & 2027
4.1.2 GLP-2
4.1.3 Growth Hormone
4.1.4 Glutamine
4.1.5 Other
4.2 By Type - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
4.2.1 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
4.2.2 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
4.2.3 By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
5.2.1 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
5.2.2 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
5.2.3 By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
6.2.1 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
6.2.2 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
6.2.3 By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Drugs for Short Bowel Syndrome Revenue, 2016-2027
6.3.2 US Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.3.3 Canada Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.3.4 Mexico Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Drugs for Short Bowel Syndrome Revenue, 2016-2027
6.4.2 Germany Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.3 France Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.4 U.K. Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.5 Italy Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.6 Russia Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.7 Nordic Countries Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.4.8 Benelux Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Drugs for Short Bowel Syndrome Revenue, 2016-2027
6.5.2 China Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.5.3 Japan Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.5.4 South Korea Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.5.5 Southeast Asia Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.5.6 India Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Drugs for Short Bowel Syndrome Revenue, 2016-2027
6.6.2 Brazil Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.6.3 Argentina Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, 2016-2027
6.7.2 Turkey Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.7.3 Israel Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.7.4 Saudi Arabia Drugs for Short Bowel Syndrome Market Size, 2016-2027
6.7.5 UAE Drugs for Short Bowel Syndrome Market Size, 2016-2027
7 Players Profiles
7.1 Ardelyx
7.1.1 Ardelyx Corporate Summary
7.1.2 Ardelyx Business Overview
7.1.3 Ardelyx Drugs for Short Bowel Syndrome Major Product Offerings
7.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.1.5 Ardelyx Key News
7.2 Emmaus Life Sciences
7.2.1 Emmaus Life Sciences Corporate Summary
7.2.2 Emmaus Life Sciences Business Overview
7.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Product Offerings
7.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.2.5 Emmaus Life Sciences Key News
7.3 GLyPharma Therapeutic
7.3.1 GLyPharma Therapeutic Corporate Summary
7.3.2 GLyPharma Therapeutic Business Overview
7.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Product Offerings
7.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.3.5 GLyPharma Therapeutic Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Drugs for Short Bowel Syndrome Major Product Offerings
7.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Product Offerings
7.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Drugs for Short Bowel Syndrome Major Product Offerings
7.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Drugs for Short Bowel Syndrome Major Product Offerings
7.4.4 OxThera Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.7.5 OxThera Key News
7.8 Sancilio & Company
7.8.1 Sancilio & Company Corporate Summary
7.8.2 Sancilio & Company Business Overview
7.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Major Product Offerings
7.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.8.5 Sancilio & Company Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Drugs for Short Bowel Syndrome Major Product Offerings
7.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.9.5 Takeda Key News
7.10 Zealand Pharma
7.10.1 Zealand Pharma Corporate Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Major Product Offerings
7.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
7.10.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Drugs for Short Bowel Syndrome Market Opportunities & Trends in Global Market
Table 2. Drugs for Short Bowel Syndrome Market Drivers in Global Market
Table 3. Drugs for Short Bowel Syndrome Market Restraints in Global Market
Table 4. Key Players of Drugs for Short Bowel Syndrome in Global Market
Table 5. Top Drugs for Short Bowel Syndrome Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drugs for Short Bowel Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drugs for Short Bowel Syndrome Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drugs for Short Bowel Syndrome Product Type
Table 9. List of Global Tier 1 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Ardelyx
Emmaus Life Sciences
GLyPharma Therapeutic
Merck
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio & Company
Takeda
Zealand Pharma

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE